Uncategorized
-
19846
This article describes attaching a drug molecule to a molecule from the rabies virus that enables the drug to cross the blood-brain barrier. This suggests a possible danger if the ability to produce the molecule could be transferred to the genomes of disease organisms in the wild. If the field of genetic engineering for drug […]
By Science News - Health & Medicine
Fluorine highlights early tumors
Microscopic, fluorine-packed particles can make small, cancerous growths easier to detect.
-
New player in cancer risk
RNA snippets of a newly discovered type could be involved in the mechanisms of cancer.
- Animals
Clownfish noisemaker is new to science
Clownfish make "pop-pop-pop" noises at each other by clacking their teeth together in a novel way.
By Susan Milius - Materials Science
Heal thyself—again and again
A new self-healing material can repeatedly repair damage at the same spot.
By Sarah Webb - Earth
Tree rings tell tale of megadroughts
Tree rings in ancient timber show that the Colorado Plateau experienced a 60-year drought in the 12th century.
By Sid Perkins - Animals
Moths mimic ‘Don’t eat me’ sounds
Moths that make clicking noises at predatory bats are mimicking a defensive signal made by other moths that click and also taste bad.
By Susan Milius -
19845
In this article, the study is reported as the “first confirmed acoustic example of classic defensive mimicry.” Not so. In 1986, Matthew P. Rowe and colleagues published in Ethology an elegant study demonstrating that the burrowing owl’s hiss is acoustic defensive mimicry of the rattlesnake’s rattle. William K. HayesLoma Linda UniversityLoma Linda, Calif.
By Science News - Archaeology
Ancient beads found in northern Africa
Perforated shells found in a Moroccan cave indicate that northern Africans made symbolic body ornaments 82,000 years ago, long before Europeans did.
By Bruce Bower -
19844
Your article reports 86 heart attacks among 15,560 rosiglitazone (Avandia) users, versus 72 others in a control group of 12,283. A study coauthor then says that “after statistical adjustment, that yields a 43 percent higher risk of heart attacks among rosiglitazone users.” Simple arithmetic would seem to indicate it was the control group that had […]
By Science News - Health & Medicine
Diabetes drug might hike heart risk
People who take rosiglitazone, a popular diabetes drug marketed as Avandia, may face an increased risk of heart attack.
By Nathan Seppa - Health & Medicine
Stents Stumble
After a meteoric rise, stents coated with drugs to prevent renarrowing of clogged arteries have begun to fall from favor among cardiologists.
By Brian Vastag